Seeking Alpha

Illumina (ILMN -5.6%), which has twice rejected Roche's (RHHBY.PK) takeover bids, drops below...

Illumina (ILMN -5.6%), which has twice rejected Roche's (RHHBY.PK) takeover bids, drops below the latest $51/share offer price for the first time as investors grow concerned the deal will be abandoned. The offer is “more than adequate to serve as a basis” to start talks and “is full, fair and extremely attractive by every conceivable financial metric,” Roche says today.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs